Daniel Vapnek

Daniel Vapnek

Corporate Officer/Principal en
University of California, Santa Barbara
.
87 años
Health Technology
Consumer Services

Perfil

Dr. Daniel Vapnek is an Advisor at Iguana Healthcare Management LLC.
He was Senior Vice president for Research at Amgen from 1981-1997.
During his tenure, scientists under his direction developed Epogen and Neupogen and discovered the RANK ligand which laid the groundwork for the development of denosumab for the treatment of osteoporosis.
For the past decade, Dr. Vapnek has been an advisor to venture capital funds and involved in several startups including BioArray solutions, which was recently sold to Immucor.
He is currently on The Board of Directors of Medicinova and an Adjunct Professor of Cellular and Molecular Biology at the University of California Santa Barbara.
Prior to joining Amgen, he was Professor of Molecular and Population Biology at the University of Georgia.
Dr. Vapnek received his undergraduate degree from the University of Miami (Florida) and a doctorate degree from the University of Miami (Florida).

Cargos activos de Daniel Vapnek

EmpresasCargoInicio
Corporate Officer/Principal -

Antiguos cargos conocidos de Daniel Vapnek.

EmpresasCargoFin
Director/Miembro de la Junta 01/04/2007
Protein Pathways, Inc.
Presidente 01/11/2004
ASPIRA WOMEN'S HEALTH INC. Director/Miembro de la Junta 01/05/2001
AMGEN INC. Director Técnico/Científico/I+D 31/12/1996
Corporate Officer/Principal -
Ver el detalle de la experiencia de Daniel Vapnek.

Formación de Daniel Vapnek.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

82

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Protein Pathways, Inc.